SHIM
PHAR

Stone House Investment Management’s Pharming Group PHAR Stock Holding History

Stone House Investment Management’s Portfolio PHAR Stock Details PHAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.31K Buy
+79
New +$1.34K ﹤0.01% 666

Other funds holding PHAR

SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $240M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Stone House Investment Management's PHAR Position: Q1 2026 in Review

Stone House Investment Management opened a new position in Pharming Group (PHAR) in Q1 2026: 79 shares worth $1.31K. The stake represents ﹤0.01% of the portfolio and ranks #666 among its holdings.

12 funds tracked by Wall St. Rank hold PHAR as of Q1 2026.

  • Stone House Investment Management held 79 shares of Pharming Group worth $1.31K as of Q1 2026.
  • Pharming Group was a new Stone House Investment Management position in Q1 2026.
  • Pharming Group made up ﹤0.01% of Stone House Investment Management's portfolio in Q1 2026, its #666 holding.
  • 12 funds tracked by Wall St. Rank held Pharming Group as of Q1 2026.

Based on Stone House Investment Management's 13F filing for Q1 2026, filed 22 Apr 2026.